Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription 30.10.2023 2 Aliment Pharmacol Ther 1 Br J Surg 4 Clin Gastroenterol Hepatol 2 Dis Colon Rectum 1 Gut 7 Inflamm Bowel Dis 2 J Crohns Colitis 1 Lancet Gastroenterol Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. SPARTZ EJ, DeDecker LC, Fansiwala KM, Noorian S, et al
   Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2023 Oct 24. doi: 10.1111/apt.17777.
   PubMed         Abstract available
   
   
2. REZAZADEH ARDABILI A, Van Bodegraven AA
   Editorial: IBD cost evolution - transitioning from compensating lost productivity to escalating medication expenses.
   Aliment Pharmacol Ther. 2023;58:832-833.
   PubMed        
   
   

   
   Br J Surg

3. PHILLIPS KE, Aljobeh A, Benammi S, Abdalla S, et al
   Predictors of ileal pouch failure due to fistulas.
   Br J Surg. 2023;110:1046-1048.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

4. YARUR AJ, McGovern D, Abreu MT, Cheifetz A, et al
   Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
   Clin Gastroenterol Hepatol. 2023;21:2908-2917.
   PubMed         Abstract available
   
   
5. LOFTUS EV JR, Paul S, Roblin X
   Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude.
   Clin Gastroenterol Hepatol. 2023;21:2193-2194.
   PubMed        
   
   
6. WANG Z, Verstockt B, Sabino J, Ferrante M, et al
   Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study.
   Clin Gastroenterol Hepatol. 2023;21:3188-3190.
   PubMed        
   
   
7. SHAH RS, Bachour S, Joseph A, Xiao H, et al
   Real World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease.
   Clin Gastroenterol Hepatol. 2023 Oct 23:S1542-3565(23)00851.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

8. SUNDEL MH, Newland JJ, Blackburn KW, Vesselinov RM, et al
   Sex-Based Differences in Inflammatory Bowel Disease Surgical Outcomes.
   Dis Colon Rectum. 2023 Oct 23. doi: 10.1097/DCR.0000000000002984.
   PubMed         Abstract available
   
   
9. BIHAIN F, Caron B, Ayav A, Peyrin-Biroulet L, et al
   Preoperative Magnetic Resonance Enterography to Predict Pathological Specimen Length in Crohn's Disease.
   Dis Colon Rectum. 2022 Aug 29. pii: 00003453-990000000-00129.
   PubMed         Abstract available
   
   

   
   Gut

10. ULLRICH KA, Derdau J, Baltes C, Battistella A, et al
    IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells.
    Gut. 2023;72:2081-2094.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

11. MASSIRONI S, Sileri P, Danese S
    Get Fit: Muscle Health for Crohn's Disease Surgical Outcome Optimization.
    Inflamm Bowel Dis. 2023 Oct 20:izad235. doi: 10.1093.
    PubMed        
    
    
12. DAL BUONO A, Armuzzi A
    Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Oct 20:izad254. doi: 10.1093.
    PubMed        
    
    
13. LUND K, Zegers FD, Nielsen J, Brodersen JB, et al
    Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 24:izad244. doi: 10.1093.
    PubMed         Abstract available
    
    
14. 
    Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Inflamm Bowel Dis. 2023 Oct 25:izad260. doi: 10.1093.
    PubMed        
    
    
15. SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
    Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2023 Oct 25:izad246. doi: 10.1093.
    PubMed         Abstract available
    
    
16. WELLENS J, Chen J, Fu T, Zhang Y, et al
    Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
    Inflamm Bowel Dis. 2023 Oct 25:izad249. doi: 10.1093.
    PubMed        
    
    
17. 
    Correction to: Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2023 Oct 27:izad261. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

18. COHEN NA, Weber CR, Cheng JX, Choi D, et al
    Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes.
    J Crohns Colitis. 2023 Oct 25:jjad174. doi: 10.1093.
    PubMed         Abstract available
    
    
19. ASSCHER VER, Rodriguez Girondo MDM, Fens J, Waars SN, et al
    Frailty screening associates with hospitalization and decline in quality of life and functional status in older patients with inflammatory bowel disease.
    J Crohns Colitis. 2023 Oct 23:jjad175. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

20. DIBLEY L, Duffy M
    Inflammatory bowel disease health care for LGTBQIA+ patients.
    Lancet Gastroenterol Hepatol. 2023 Oct 20:S2468-1253(23)00352.
    PubMed        
    
    

    
    PLoS One

21. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
    Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
    PLoS One. 2023;18:e0293389.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.